Letter Concerning Medicare Should Not Cover Aducanumab as a Treatment for Alzheimer's Disease by Moghavem, Henderson, and Greicius

Annals of NeurologyVolume 90, Issue 6 p. 1004-1006 Letters/Replies Letter Concerning Medicare Should Not Cover Aducanumab as a Treatment for Alzheimer's Disease by Moghavem, Henderson, and Greicius Alfred Sandrock MD, PhD, Corresponding Author Alfred Sandrock MD, PhD alfred.sandrock@biogen.com Research & Development, Biogen, Cambridge, MA, USA Address correspondence to Dr Alfred Sandrock, Research & Development, Biogen, 225 Binney Street,...